PrimeRFP SCOUT · Federal Contract Profile

Caredx (Y371A27ZEUM4)Federal contracts · 9 recompetes

Caredx holds $10.5M in federal volume across 27 award actions, with 100% at Department of Veterans Affairs (VA). SCOUT tracks 9 incumbent recompetes — an estimated $6.1M returning to market over the next 24 months (High exposure). Primary work: Medical Laboratories; Testing Laboratories (100% prime). Obligations are up 312% year over year.

$10.5M

Federal Volume

Recompetes (24mo)

Top Agency · 100% firm-wide

27

Award Actions

Choose one — this changes what we ask next

Score my firm against Caredx

Email me when a Caredx recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

MEDICAL LABORATORIES · TESTING LABORATORIES · TESTING LABORATORIES AND SERVICES

Work mix: 100% prime · 0% sub · primary NAICS 621511 / PSC 6640 LABORATORY EQUIPMENT AND SUPPLIES

Where they win

Sole agency

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$10.5M · 100% of firm total

Recompete exposure: High · 9 in 24mo

Caredx has an estimated $6.1M in contracts returning to market over the next 24 months.

Who buys from them

Agency buyer map

1 buyers

Department of Veterans Affairs (VA)65 awards · repeat buyer · $10.5M

Recompete exposure & trajectory

Recompete exposure

High

Caredx has an estimated $6.1M in contracts returning to market over the next 24 months. 3 within 6 months ($2.6M).

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE) →

PIID: 36C24925N0545 · Expires 2026-09-22

$492K

ALLOSURE KIDNEY TESTING →

PIID: 36C25221N0645 · Expires 2026-09-29

$486K

TRANSPLANT TESTING KITS →

PIID: 36C25226N0079 · Expires 2027-01-31

$1.6M

ALLOMAP AND ALLOSURE POST HEART TRANSPLANT REJECTION SURVEILLANCE TESTS SERVICES →

PIID: 36C26122C0017 · Expires 2027-02-28

$1.3M

LAB TESTS FOR POST TRANSPLANT CARE. →

PIID: 36C25626N0370 · Expires 2027-03-31

$771K

ALLOMAP GENE TESTING →

PIID: 36C25922C0115 · Expires 2027-07-31

$117K

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE) →

PIID: 36C24926N0622 · Expires 2027-09-22

$1.0M

ALLOSURE KIDNEY TEST →

PIID: 36C24623P0011 · Expires 2027-10-18

$171K

ALLOSURE IN-HOME PATIENT TESTING →

PIID: 36C26326N0261 · Expires 2028-01-13

$142K

Trajectory

▲ Expanding+312% YoYFY2025 vs FY2024

'23

'24

'25

“After 35 years in federal contracting, I've seen what separates the firms that win from the ones that wonder why they lost. What SCOUT does is put the kind of competitive and market intelligence in front of BD teams…”

— Shauna Weatherly, FedSubK

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Caredx hold?

Caredx (UEI Y371A27ZEUM4) shows $10.5M across 27 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Caredx have?

Caredx shows $10.5M across 27 award actions. SCOUT tracks 9 incumbent recompetes ($6.1M) returning to market in the next 24 months.

Which agencies does Caredx work with?

Caredx’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (100%).

What is the UEI for Caredx?

The Unique Entity ID (UEI) for Caredx is Y371A27ZEUM4.

Does Caredx have contracts coming up for recompete?

Yes — SCOUT tracks 9 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.